Silverarc Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Silverarc Capital Management's BIIB Position: Q2 2026 in Review
Silverarc Capital Management reduced its Biogen (BIIB) stake by 5.6% in Q2 2026, selling an estimated $548K and leaving 48,101 shares worth $10.4M. The position accounts for 1.08% of the portfolio, ranked #31.
Silverarc Capital Management first reported a position in BIIB in Q4 2020 and has held it in 18 quarters since. The position peaked at $13.3M in Q4 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Silverarc Capital Management held 48,101 shares of Biogen worth $10.4M as of Q2 2026.
- Silverarc Capital Management sold 2,866 Biogen shares in Q2 2026, an estimated $548K.
- Biogen made up 1.08% of Silverarc Capital Management's portfolio in Q2 2026, its #31 holding.
- Silverarc Capital Management first reported a position in Biogen in Q4 2020 and has held it in 18 quarters since.
- Silverarc Capital Management's Biogen position peaked at $13.3M in Q4 2025.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.